RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kehinde Idowu to Humans

This is a "connection" page, showing publications Kehinde Idowu has written about Humans.
Connection Strength

0.077
  1. Sabiu S, Idowu K. An insight on the nature of biochemical interactions between glycyrrhizin, myricetin and CYP3A4 isoform. J Food Biochem. 2022 03; 46(3):e13831.
    View in: PubMed
    Score: 0.037
  2. Kehinde IA, Egbejimi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2. J Mol Graph Model. 2022 07; 114:108201.
    View in: PubMed
    Score: 0.020
  3. Onyenaka C, Idowu KA, Ha NP, Graviss EA, Olaleye OA. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023 Dec 05; 24(24).
    View in: PubMed
    Score: 0.011
  4. Uhomoibhi JO, Shode FO, Idowu KA, Sabiu S. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2. J Mol Graph Model. 2022 07; 114:108185.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support